{
    "organizations": [],
    "uuid": "4d53f83bfbca8c0147046b7a30b2161ccbf6f224",
    "author": "",
    "url": "https://www.reuters.com/article/brief-abbvie-ceo-to-discuss-dividend-gro/brief-abbvie-ceo-to-discuss-dividend-growth-share-buybacks-with-board-idUSL2N1PL0Z0",
    "ord_in_thread": 0,
    "title": "BRIEF-Abbvie CEO To Discuss Dividend Growth, Share Buybacks With Board",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 18 PM / Updated 14 minutes ago BRIEF-Abbvie CEO To Discuss Dividend Growth, Share Buybacks With Board   Abbvie Inc: \n* ABBVIE SEES 2018 NON-GAAP U.S. TAX RATE OF 9 PERCENT GRADUALLY RISING TO 13 PERCENT OVER NEXT 5 YEARS; CORRECTS FROM GAAP \n* ABBVIE SAYS PLANS TO FILE FOR VENCLEXTA APPROVAL IN AML LATER THIS YEAR \n* ABBVIE SAYS VENCLEXTA AML APPROVAL COULD COME 2 YEARS AHEAD OF INITIAL EXPECTATIONS \n* ABBVIE SEES Q1 ADJUSTED EPS $1.70 TO $1.79; OPERATING PERCENTAGE REVENUE GROWTH APPROACHING MID TEENS \n* ABBVIE CEO SAYS LOOKING FOR ASSETS THAT CAN DRIVE STRONG GROWTH IN 2023-2025 TIME FRAME \n* ABBVIE CEO SAYS TO DISCUSS ACCELERATION OF DIVIDEND GROWTH, SHARE BUYBACKS WITH BOARD Source text for Eikon:   (Reporting By Bill Berkrot)",
    "published": "2018-01-26T17:17:00.000+02:00",
    "crawled": "2018-01-26T17:40:08.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "ceo",
        "discus",
        "dividend",
        "growth",
        "share",
        "buyback",
        "board",
        "abbvie",
        "inc",
        "abbvie",
        "see",
        "tax",
        "rate",
        "percent",
        "gradually",
        "rising",
        "percent",
        "next",
        "year",
        "corrects",
        "gaap",
        "abbvie",
        "say",
        "plan",
        "file",
        "venclexta",
        "approval",
        "aml",
        "later",
        "year",
        "abbvie",
        "say",
        "venclexta",
        "aml",
        "approval",
        "could",
        "come",
        "year",
        "ahead",
        "initial",
        "expectation",
        "abbvie",
        "see",
        "q1",
        "adjusted",
        "eps",
        "operating",
        "percentage",
        "revenue",
        "growth",
        "approaching",
        "mid",
        "teen",
        "abbvie",
        "ceo",
        "say",
        "looking",
        "asset",
        "drive",
        "strong",
        "growth",
        "time",
        "frame",
        "abbvie",
        "ceo",
        "say",
        "discus",
        "acceleration",
        "dividend",
        "growth",
        "share",
        "buyback",
        "board",
        "source",
        "text",
        "eikon",
        "reporting",
        "bill",
        "berkrot"
    ]
}